von Both U, Alberer M, 2016. Borrelia recurrentis infection. N Engl J Med 375: e5.
ECDC, 2015. Louse-Borne Relapsing Fever in the EU. Rapid Risk Assessment. Stockholm, Sweden: European Centre for Disease Prevention and Control.
Fauci ASBE, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, 2008. Harrison’s Principles of Internal Medicine. New York, NY: McGraw-Hill Professional.
Seboxa T, Rahlenbeck SI, 1995. Treatment of louse-borne relapsing fever with low dose penicillin or tetracycline: a clinical trial. Scand J Infect Dis 27: 29–31.
EFMHACA, 2014. Standard Treatment Guidelines For General Hospital. Addis Ababa, Ethiopia: Food, Medicine and Healthcare Administration and Control Authority of Ethiopia, 681.
Raoult D, Roux V, 1999. The body louse as a vector of reemerging human diseases. Clin Infect Dis 29: 888–911.
Cutler SJ, Abdissa A, Trape JF, 2009. New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect 15: 400–406.
Yimer M, Mulu W, Ayalew W, Abera B, 2014. Louse-borne relapsing fever profile at Felegehiwot referral hospital, Bahir Dar city, Ethiopia: a retrospective study. BMC Res Notes 7: 250.
Cutler SJ, 2010. Relapsing fever-a forgotten disease revealed. J Appl Microbiol 108: 1115–1122.
Borgnolo G, Hailu B, Chiabrera F, 1991. Louse-borne relapsing fever in Ethiopia. Lancet 338: 827.
Tizazu G, Anteneh T, 2006. Relapsing Fever. Addis Abeba, Ethiopia: Carter Center, Ethiopian Ministry of Health, Ethiopian Ministry of Education.
WHO, 2016. Ethiopia–Health Profile. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/countries/eth/coop_strategy/en/. Accessed 2016.
Animut A, Mekonnen Y, Shimelis D, Ephraim E, 2009. Febrile illnesses of different etiology among outpatients in four health centers in northwestern Ethiopia. Jpn J Infect Dis 62: 107–110.
Zein ZA, 1987. Louse borne relapsing fever (LBRF): mortality and frequency of Jarisch-Herxheimer reaction. J R Soc Health 107: 146–147.
Perine PL, Teklu B, 1983. Antibiotic treatment of louse-borne relapsing fever in Ethiopia: a report of 377 cases. Am J Trop Med Hyg 32: 1096–1100.
Borgnolo G, Hailu B, Ciancarelli A, Almaviva M, Woldemariam T, 1993. Louse-borne relapsing fever. A clinical and an epidemiological study of 389 patients in Asella Hospital, Ethiopia. Trop Geogr Med 45: 66–69.
Ramos JM, Malmierca E, Reyes F, Tesfamariam A, 2008. Results of a 10-year survey of louse-borne relapsing fever in southern Ethiopia: a decline in endemicity. Ann Trop Med Parasitol 102: 467–469.
Guerrier G, Doherty T, 2011. Comparison of antibiotic regimens for treating louse-borne relapsing fever: a meta-analysis. Trans R Soc Trop Med Hyg 105: 483–490.
Salih SY, Mustafa D, 1977. Louse-borne relapsing fever: II. Combined penicillin and tetracycline therapy in 160 Sudanese patients. Trans R Soc Trop Med Hyg 71: 49–51.
Garedew-Kifelew L, Wondafrash N, Feleke A, 2014. Identification of drug-resistant Salmonella from food handlers at the University of Gondar, Ethiopia. BMC Res Notes 7: 545.
WHO, 2016. Analytical Summary–Health Financing System. Geneva, Switzerland: World Health Organization.
Yimer M, Abera B, Mulu W, Bezabih B, Mohammed J, 2014. Prevalence and risk factors of louse-borne relapsing fever in high risk populations in Bahir Dar city northwest, Ethiopia. BMC Res Notes 7: 615.
Antinori S, Mediannikov O, Corbellino M, Raoult D, 2016. Louse-borne relapsing fever among east African refugees in Europe. Travel Med Infect Dis 14: 110–114.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1152 | 981 | 43 |
Full Text Views | 655 | 8 | 3 |
PDF Downloads | 148 | 8 | 3 |
We report epidemiological and clinical aspects of an outbreak of louse-borne relapsing fever (LBRF) in Asella in Arsi Zone, central Ethiopia, from July to November 2016. A total of 63 LBRF cases were reported. The overall case fatality rate was 13% among treated patients. In this article, the first-line epidemiological assessment, individual prevention and control measures, and public health investigations and interventions in relation to this outbreak are described. Treatment recommendations for resource-limited settings are discussed by review of the latest literature.
Authors’ addresses: Tamara Nordmann and Matthias Bosselmann, Hirsch Institute of Tropical Medicine, College of Health Science, Arsi University, Asella, Ethiopia, and Department of Gastroenterology, Hepatology and Infectious Disease, Heinrich-Heine-Universitat Düsseldorf, Düsseldorf, Germany, E-mails: tamaranordmann@hotmail.com and matthias.bosselmann@med.uni-duesseldorf.de. Torsten Feldt, Martha Holtfreter, and Dieter Häussinger, Department of Gastroenterology, Hepatology and Infectious Disease, Heinrich-Heine-Universitat Düsseldorf, Düsseldorf, Germany, E-mails: torsten.feldt@med.uni-duesseldorf.de, martha.Holtfreter@med.uni-duesseldorf.de, and haeussinger@med.uni-duesseldorf.de. Tafese Beyene Tufa and Gorfnesh Lemma, Hirsch Institute of Tropical Medicine, College of Health Science, Arsi University, Asella, Ethiopia, E-mails: tafeseb.tufa@yahoo.com and gorfnesh.lemma@yahoo.com.
von Both U, Alberer M, 2016. Borrelia recurrentis infection. N Engl J Med 375: e5.
ECDC, 2015. Louse-Borne Relapsing Fever in the EU. Rapid Risk Assessment. Stockholm, Sweden: European Centre for Disease Prevention and Control.
Fauci ASBE, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, 2008. Harrison’s Principles of Internal Medicine. New York, NY: McGraw-Hill Professional.
Seboxa T, Rahlenbeck SI, 1995. Treatment of louse-borne relapsing fever with low dose penicillin or tetracycline: a clinical trial. Scand J Infect Dis 27: 29–31.
EFMHACA, 2014. Standard Treatment Guidelines For General Hospital. Addis Ababa, Ethiopia: Food, Medicine and Healthcare Administration and Control Authority of Ethiopia, 681.
Raoult D, Roux V, 1999. The body louse as a vector of reemerging human diseases. Clin Infect Dis 29: 888–911.
Cutler SJ, Abdissa A, Trape JF, 2009. New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect 15: 400–406.
Yimer M, Mulu W, Ayalew W, Abera B, 2014. Louse-borne relapsing fever profile at Felegehiwot referral hospital, Bahir Dar city, Ethiopia: a retrospective study. BMC Res Notes 7: 250.
Cutler SJ, 2010. Relapsing fever-a forgotten disease revealed. J Appl Microbiol 108: 1115–1122.
Borgnolo G, Hailu B, Chiabrera F, 1991. Louse-borne relapsing fever in Ethiopia. Lancet 338: 827.
Tizazu G, Anteneh T, 2006. Relapsing Fever. Addis Abeba, Ethiopia: Carter Center, Ethiopian Ministry of Health, Ethiopian Ministry of Education.
WHO, 2016. Ethiopia–Health Profile. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/countries/eth/coop_strategy/en/. Accessed 2016.
Animut A, Mekonnen Y, Shimelis D, Ephraim E, 2009. Febrile illnesses of different etiology among outpatients in four health centers in northwestern Ethiopia. Jpn J Infect Dis 62: 107–110.
Zein ZA, 1987. Louse borne relapsing fever (LBRF): mortality and frequency of Jarisch-Herxheimer reaction. J R Soc Health 107: 146–147.
Perine PL, Teklu B, 1983. Antibiotic treatment of louse-borne relapsing fever in Ethiopia: a report of 377 cases. Am J Trop Med Hyg 32: 1096–1100.
Borgnolo G, Hailu B, Ciancarelli A, Almaviva M, Woldemariam T, 1993. Louse-borne relapsing fever. A clinical and an epidemiological study of 389 patients in Asella Hospital, Ethiopia. Trop Geogr Med 45: 66–69.
Ramos JM, Malmierca E, Reyes F, Tesfamariam A, 2008. Results of a 10-year survey of louse-borne relapsing fever in southern Ethiopia: a decline in endemicity. Ann Trop Med Parasitol 102: 467–469.
Guerrier G, Doherty T, 2011. Comparison of antibiotic regimens for treating louse-borne relapsing fever: a meta-analysis. Trans R Soc Trop Med Hyg 105: 483–490.
Salih SY, Mustafa D, 1977. Louse-borne relapsing fever: II. Combined penicillin and tetracycline therapy in 160 Sudanese patients. Trans R Soc Trop Med Hyg 71: 49–51.
Garedew-Kifelew L, Wondafrash N, Feleke A, 2014. Identification of drug-resistant Salmonella from food handlers at the University of Gondar, Ethiopia. BMC Res Notes 7: 545.
WHO, 2016. Analytical Summary–Health Financing System. Geneva, Switzerland: World Health Organization.
Yimer M, Abera B, Mulu W, Bezabih B, Mohammed J, 2014. Prevalence and risk factors of louse-borne relapsing fever in high risk populations in Bahir Dar city northwest, Ethiopia. BMC Res Notes 7: 615.
Antinori S, Mediannikov O, Corbellino M, Raoult D, 2016. Louse-borne relapsing fever among east African refugees in Europe. Travel Med Infect Dis 14: 110–114.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1152 | 981 | 43 |
Full Text Views | 655 | 8 | 3 |
PDF Downloads | 148 | 8 | 3 |